Levothyroxine Sodium is a synthetic thyroid hormone (T4) indicated for hypothyroidism and pituitary TSH suppression. We supply it to US manufacturers of tablets, capsules and injection.
Data from PubChem (CID 23666112) and FDA’s substance registry
CAS number
55-03-8
Molecular formula
C15H10I4NNaO4
Molecular weight
798.9g/mol
FDA UNII
IUPAC name
sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
InChIKey
YDTFRJLNMPSCFM-YDALLXLXSA-M
- Appearance
- Almost white to pale brownish-yellow powder, or fine, slightly colored crystalline powder.
- Solubility
- Very slightly soluble in water and slightly soluble in ethanol. Dissolves in dilute solutions of alkali hydroxides.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
A narrow therapeutic index drug dosed in micrograms. The API degrades with heat, light and moisture, so potency, water content and stability data carry more weight here than price.
On the US market
- Reference product
- SynthroidNDA 021402
- Approved ANDAs
- 11 with a marketed product
- Approved forms and strengths
- Tablet 0.025 mg to 0.3 mg, in 12 strengths
- Oral solution 13 mcg/mL to 175 mcg/mL, in 12 strengths
- Capsule 0.013 mg to 0.2 mg, in 12 strengths
- Powder for injection 100 mcg per vial, 200 mcg per vial, 500 mcg per vial
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com